SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-09-066193
Filing Date
2009-03-27
Accepted
2009-03-27 16:59:08
Documents
5
Effectiveness Date
2009-03-27

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ds8.htm S-8 37637
2 OPINION OF ORRICK, HERRINGTON & SUTCLIFFE LLP dex51.htm EX-5.1 6971
3 CONSENT OF STONEFIELD JOSEPHSON, INC. dex231.htm EX-23.1 1495
4 GRAPHIC g46134g10j79.jpg GRAPHIC 4537
5 GRAPHIC g46134g84b65.jpg GRAPHIC 3132
  Complete submission text file 0001193125-09-066193.txt   58371
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-158260 | Film No.: 09711118
SIC: 2834 Pharmaceutical Preparations